August 14, 2015
July 27, 2015
July 20, 2015
June 11, 2015
CASI Pharmaceuticals CEO Ken K. Ren, PhD rang the closing bell at NASDAQ on Thursday, June 11, 2015 4PM. Click the link below to access NASDAQ’s video archive to view the ceremony. http://www.nasdaq.com/marketsite/marketsite-events-detail.aspx?fn=201506-close06112015.txt
A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.
EntreMed leverages best of China and the West and seeks to expand pipeline.
Phase II Study of Oral ENMD-2076 Administered to Patients (pts) With Advanced Soft Tissue Sarcoma
Phase II Study of Oral ENMD-2076 Administered to Patients with Ovarian Clear Cell Carcinoma